This study benchmarks transformer models for Bangla medical named entity recognition (NER), comparing BanglaBERT, multilingual BERT (mBERT), XLM‑RoBERTa, and GPT‑4o mini under zero‑shot and few‑shot prompting. Across a full test set of 3,179 samples, fine‑tuned XLM‑RoBERTa achieves a new state‑of‑the‑art F1‑score of 0.5959, while BanglaBERT lags with 0.4937, suggesting that domain diversity outweighs language specificity. The analysis shows high performance on Medicine and Specialist entities (F1 > 0.83) but lower accuracy on Symptoms (F1 0.4367), and demonstrates that fine‑tuned transformers outperform prompt‑only approaches by a factor of 3.76.
By Rakib Abdullah, Md. Maruful Islam Maruf
arXiv:2606. 01904v1 Announce Type: cross Abstract: The increasing application of Natural Language Processing (NLP) in healthcare demands language models specifically attuned to the complexities of clinical language.
By Christian Autenried, Cosimo Persia
arXiv:2606. 24102v1 Announce Type: cross Abstract: Most electronic health record (EHR) foundation models encode clinical events as discrete event tokens from a fixed vocabulary and therefore cannot directly represent events containing unseen concepts or new combinations of concepts and attributes such as numeric values.
By Lin Lawrence Guo, Adam Paul Yan, Emily Vettese, Lillian Sung
The paper introduces a web‑data curation recipe for pretraining medical encoders, addressing the scarcity of large, diverse corpora in dense‑terminology domains like medicine. It proposes two complementary techniques: medical‑term density filtering to select documents rich in medical terminology, and signal‑amplifying rephrasing that uses an LLM to rewrite documents into denser variants with broader entity contexts. Applied to French medical NLP, the recipe produces the FineMed corpus and the DoctoBERT encoder family, achieving state‑of‑the‑art results on the DrBenchmark public benchmark and a proprietary clinical NER task.
By Bofeng Huang, Jacques Sun, Diane Bouchacourt, Nicolas Barascud, Fajwel Fogel
SCOUT is a concept‑grounded multimodal transformer that generates whole‑slide pathology reports by integrating local histological patterns, whole‑slide context, and expert‑curated diagnostic concepts. It uses evolving visual representations and recursively updated slide‑ and concept‑conditioned representations, with separate attention pathways during decoding that are fused adaptively for each token. Evaluated on TCGA‑BRCA, HistAI, and REG‑2025, SCOUT outperformed existing methods, improving BLEU, METEOR, and ROUGE‑L scores and raising the Clinical Report Quality Score on REG‑2025.
By Suryakant Singh, Saarthak Kapse, Joel Saltz, Prateek Prasanna
arXiv:2608. 02615v1 Announce Type: cross Abstract: Cancer diagnosis and characterization require integrating complementary evidence from radiology, pathology, genomics, and clinical metadata.
By Ahnaf Munir, Dannong Wang, Michael W. McDonald, Mubarak Shah, Pegah Khosravi, Yu Tian
The paper introduces a comparative explainability framework for auditing DeBERTa‑v3 in zero‑shot medical abstract classification. It evaluates five explanation methods—SHAP, LIME, occlusion, Input × Gradient, and Attention × Gradient—using a natural language inference engine on a balanced corpus of 1,000 abstracts per diagnostic category. The study finds that explanatory stability aligns with predictive certainty, identifies three systemic failure mechanisms, and recommends combining multiple explanation methods and quantitative agreement metrics for transformer‑based medical text classifiers.
By Javier Diaz Esteban-Herreros, David Mu\~noz-Valero, Raquel Mart\'inez-Espa\~na, Jose M. Juarez, Juan Moreno-Garcia
arXiv:2607. 14116v1 Announce Type: cross Abstract: Free-form radiology reports contain rich clinical descriptions, yet converting them for reliable segmentation remains challenging due to the inherent variability of natural language.
By Anghong Du, Theodoros N. Arvanitis, Colin Watts, Alejandro F. Frangi, Le Zhang
This thesis explores how to select and adapt NLP models for global health literature when annotated data and computational resources are scarce. It compares skip‑gram word2vec models trained on increasingly large specialized corpora with BioWordVec for semantic tag discovery, finding that larger coverage does not always yield more useful domain associations. The study also evaluates convolutional spaCy models versus a RoBERTa transformer for named entity recognition, noting a trade‑off between higher F1 scores and longer inference time, and investigates MiniLM few‑shot versus BART‑MNLI zero‑shot classification for multi‑label topic classification, highlighting practical constraints of inference cost.
"whyItMatters":"The work provides empirical guidance on balancing model accuracy and resource demands for building knowledge systems in low‑resource global health settings."
By Genis Skura, Antoine Geissb\"uhler, Jean-Luc Falcone
OpenMTB‑Audit is an open‑source benchmark that tests large language models on 500 synthetic non‑small cell lung cancer cases, covering five adversarial error categories and four safety labels: Supported, Partially Supported, Unsupported, and Insufficient Information. The study found that all eight tested LLMs over‑refused Partially Supported recommendations, collapsing labels to achieve high safety scores. A deterministic seven‑module framework, MTB‑AuditAgent, was introduced to reduce over‑refusal to 6.7% and reach 91.2% accuracy, while an oncologist annotation study highlighted disagreement around the boundary between information sufficiency and treatment optimization.
By Negin Ashrafi, Jia Luo, Stacey M. Frumm, Roxana Daneshjou
An end-to-end-trained vision-language model generates prostate biopsy reports in native languages, demonstrated in German. The system uses a tokenizer and model trained from scratch and an automated pipeline that splits composite reports into image-text pairs, producing 17,344 pairs from 2,402 cases without manual annotation. Evaluated on clinical attributes, it achieves 96.2% F1 for malignancy detection and 65.2% for Gleason grading, comparable to an FDA-cleared classifier and validated on external cohorts.
By Christian Grashei, Fabian G\"ulhan, Maximilian Legnar, Fabian St\"ogbauer, Cleo-Aron Weis, Carolin Mogler, Peter Sch\"uffler
HERO (Histology Encoder for Robust Representation in Oncology) is a ViT‑G/14 pathology foundation model trained with DINO and iBOT objectives and refined using high‑resolution Gram anchoring on a 500‑million‑tile corpus from about 575,000 clinical whole‑slide images. It demonstrates superior robustness to center, scanner, and stain variation compared to other state‑of‑the‑art foundation models, while maintaining competitive performance on tile‑level classification, segmentation, and gene‑expression prediction. Across 39 slide‑level clinical tasks, HERO ranks first on average and achieves the best average rank across six benchmark frameworks under an equal‑weighted analysis.
By Zhi Li (Caris Life Sciences, Irving, TX, United States), Eghbal Amidi (Caris Life Sciences, Irving, TX, United States), Yating Cheng (Caris Life Sciences, Irving, TX, United States), Tyson Dawson (Caris Life Sciences, Irving, TX, United States), Gorkem Can Ates (Caris Life Sciences, Irving, TX, United States), Shuzhen Kuang (Caris Life Sciences, Irving, TX, United States), Norsang Lama (Caris Life Sciences, Irving, TX, United States), Md Ashequr Rahman (Caris Life Sciences, Irving, TX, United States), Zhiying Lu (Caris Life Sciences, Irving, TX, United States), Elisabeth K. Kong (Caris Life Sciences, Irving, TX, United States), Milan Radovich (Caris Life Sciences, Irving, TX, United States), David Spetzler (Caris Life Sciences, Irving, TX, United States), Matthew Oberley (Caris Life Sciences, Irving, TX, United States), George W. Sledge (Caris Life Sciences, Irving, TX, United States), Ming Chen (Caris Life Sciences, Irving, TX, United States)